UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly
LONDON, Feb 5 (Reuters) - British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on FridayBritain...
Read more